Antibody-Based Cancer Therapies banner

The success of monoclonal antibodies as a therapeutic class for cancer has given rise to the development of various types of therapeutic antibodies, including antibody-drug conjugates, intracellular antibodies, conditionally-active biologics, bispecifics, multi-specifics and multi-valent antibodies, etc. At PEGS Europe's inaugural Antibody-Based Cancer Therapies conference, we will showcase the latest and hottest in these therapeutic approaches, and explore the molecules' mechanisms, engineering, as well as preclinical to clinical translation.

Recommended Short Course*
Monday, 13 November, 14:00 – 17:00
SC2: Developability of Bispecific Antibodies: Formats and Applications
*Separate registration required. See short courses page for details. All short courses take place in-person only.

For more details on the conference, please contact:

Mimi Langley
Senior Conference Director
Cambridge Healthtech Institute
Phone: (+1) 781-972-5439

For sponsorship information, please contact:

Companies A-K
Jason Gerardi
Sr. Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-972-5452

Companies L-Z
Ashley Parsons
Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-972-1340